期刊文献+

规范化治疗——风湿病领域永恒的话题 被引量:11

原文传递
导出
摘要 近年来,“规范化治疗”的概念已在不少学科受到关注,并促进了临床治疗水平的提高。风湿病学作为内科领域发展最快的学科之一.规范化治疗更是不容忽视。临床上.因不正规用药导致病情迁延不愈、出现内脏损害甚至致残的风湿病患者绝不在少数。最近又读到几篇国外关于“规范化”或“系统性”治疗类风湿关节炎(RA)和系统性红斑狼疮(SLE)等的文章,更促使我动笔将近几年国内外的临床研究以及自己的思考写成此文,供同道们参考。
作者 栗占国
出处 《中华风湿病学杂志》 CAS CSCD 2007年第6期321-323,共3页 Chinese Journal of Rheumatology
  • 相关文献

参考文献18

  • 1ACR Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of RA. Arthritis Rheum, 2002, 46: 328- 346.
  • 2Luqmani R, Hennell S, Estrach C, et al. British society for rheumatology and British health professionals in meumatology guideline for the management of rheumatoid arthritis (the first two years). Rheumatology, 2006, 45:1167-1169.
  • 3类风湿关节炎诊治指南(草案)[J].中华风湿病学杂志,2003,7(4):250-254. 被引量:430
  • 4Choy EHS, Smith C, Dore DCJ, et al. A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology, 2005, 44: 1414-1421.
  • 5Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet, 2004, 364: 263-269.
  • 6栗占国.重视类风湿关节炎的规范化治疗[J].中华风湿病学杂志,2003,7(8):459-461. 被引量:13
  • 7Nell VP, Machold KP, Eberl G, et al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford), 2004, 43: 906-914.
  • 8Suresh E, Lambert CM. Combination treatment strategies in early rheumatoid arthritis. Ann Rheum Dis, 2005, 64: 1252-1256.
  • 9Grootscholten C, Bajema IM, Florquin S, et al. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylpred- nisolone in patients with proliferative lupus nephritis. Arthritis Rheum, 2007, 56: 924-937.
  • 10Cortes-Hernandez J, Ordi-Ros J, labrador M, et al. Predictors of poor renal outcome in patients with lupus nephritis with combined pulses of cyclophosphamide and methylprednisolone. Lupus, 2003, 12: 287-296.

二级参考文献16

  • 1张学武,张幼丽,陈适,贾园,穆荣,栗占国.免疫净化对难治性类风湿性关节炎治疗效果的观察[J].中国血液净化,2002,1(4):43-44. 被引量:6
  • 2姜林娣,Peter Tugwell.痛风和高尿酸血症处理中的循证医学观点[J].中华风湿病学杂志,2005,9(2):120-122. 被引量:16
  • 3施桂英.走出痛风性关节炎诊断和治疗的误区[J].中华全科医师杂志,2006,5(9):519-522. 被引量:51
  • 4Mikuls TR, Farrar JT, Bilker WB, et al. Gout epidemiology: resuits from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis, 2005, 64: 267-272.
  • 5Wallace SI, Singer J. Therapy in gout. Rheum Dis Clin N Am,1988, 14: 441-457.
  • 6Schumacher HR, Chen LX. Newer therapeutic approaches: gout.Rheum Dis Clin N Am, 2006, 32: 235-244.
  • 7Becker MA, Schumacher HR, Wortamann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med, 2005, 353: 2450-2461.
  • 8Bruce J. Febuxostat staved off gout flares during 4-year study.Rheumatol News, 2006, 5: 1.
  • 9Nuki G. Treatment of crystal arthropathy-history and advances.Rheum Dis Clin N Am, 2006, 32: 333-357.
  • 10Richette P. Rasburicase in treatment-failure gout. ACR Annual Scientific Meeting. 2006, Presentation 704.

共引文献459

同被引文献96

引证文献11

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部